During ischemia and reperfusion, with an increase in intracellular Na ϩ and a depolarized membrane potential, Ca 2ϩ may enter the myocyte in exchange for intracellular Na ϩ via reverse-mode Na ϩ -Ca 2ϩ exchange (NCX). To test the role of Ca 2ϩ entry via NCX during ischemia and reperfusion, we studied mice with cardiac-specific ablation of NCX (NCX-KO) and demonstrated that reverse-mode Ca 2ϩ influx is absent in the NCX-KO myocytes. Langendorff perfused hearts were subjected to 20 minutes of global ischemia followed by 2 hours of reperfusion, during which time we monitored high-energy phosphates using 31 P-NMR and left-ventricular developed pressure. In another group of hearts, we monitored intracellular Na ϩ using 23 Na-NMR. Consistent with Ca 2ϩ entry via NCX during ischemia, we found that hearts lacking NCX exhibited less of a decline in ATP during ischemia, delayed ischemic contracture, and reduced maximum contracture. Furthermore, on reperfusion following ischemia, NCX-KO hearts had much less necrosis, better recovery of left-ventricular developed pressure, improved phosphocreatine recovery, and reduced Na ϩ overload. The improved recovery of function following ischemia in NCX-KO hearts was not attributable to the reduced preischemic contractility in NCX-KO hearts, because when the preischemic workload was matched by treatment with isoproterenol, NCX-KO hearts still exhibited improved postischemic function compared with wild-type hearts. Thus, NCX-KO hearts were significantly protected against ischemia-reperfusion injury, suggesting that Ca 2ϩ entry via reverse-mode NCX is a major cause of ischemia/reperfusion injury. (Circ Res. 2005;97:916-921.) 
A rise in intracellular Na ϩ occurs during ischemia followed by a rise in intracellular Ca 2ϩ . A substantial proportion of the rise in Ca 2ϩ is dependent on the rise in intracellular Na ϩ suggesting an important role for Na ϩ -Ca 2ϩ exchange (NCX). [1] [2] [3] [4] [5] [6] The NCX is a transporter that exchanges 3 Na ϩ for 1 Ca 2ϩ ; it is therefore electrogenic and influenced by membrane potential as well as the Na ϩ and Ca 2ϩ gradients. Thus, depending on the Na ϩ and Ca 2ϩ gradients and the membrane potential, the exchanger can extrude Ca 2ϩ from the cell (the forward mode) or transport Ca 2ϩ into the cell (reverse mode). 7, 8 The Na ϩ -dependent increase in Ca 2ϩ during ischemia and reperfusion could result from reduced Ca 2ϩ efflux caused by a reduced Na ϩ gradient or from Ca 2ϩ entry via reverse-mode NCX. 4 If the rise in Ca 2ϩ is primarily attributable to reduced Ca 2ϩ efflux, then inhibition of NCX might increase the rise in Ca 2ϩ and exacerbate injury. In contrast, if NCX operates in reverse mode to bring Ca 2ϩ into the myocyte, then NCX inhibitors should be cardioprotective. Inhibitors of NCX are under development as therapies to reduce ischemic injury, 9, 10 and it is important to clearly demonstrate whether inhibition is beneficial. However, the role and direction of NCX during ischemia is debated, as is the relative role of NCX during ischemia versus reperfusion. 7 The lack of selective inhibitors for NCX have made it difficult to directly examine the role and direction of NCX during ischemia and reperfusion. 11 Experiments with mice that overexpress NCX 12, 13 show increased ischemia/reperfusion injury, and the recent development of mice with cardiacspecific ablation of NCX provides a unique opportunity to evaluate the role of NCX in ischemia/reperfusion injury.
Much of the data suggesting a role for Ca 2ϩ during ischemia arise from studies showing that inhibition of Na ϩ /H ϩ exchange (NHE) is cardioprotective and blocks the rise in Na ϩ and Ca 2ϩ during ischemia. 4, 14 The protection afforded by NHE inhibition has generally been attributed to inhibition of the rise in Ca 2ϩ , but there are studies suggesting that inhibition of the rise in Na ϩ may also contribute to cardioprotection, independent of the effect of Na ϩ on Ca 2ϩ . 15, 16 Because NHE inhibitors block both the rise in Ca 2ϩ and Na ϩ , they cannot be used to distinguish the relative protective effects of attenuating the rise in Na ϩ versus Ca 2ϩ . Ablation of NCX would not block Na ϩ entry via NHE and thus should be useful in distinguishing the beneficial effect of attenuating Na ϩ versus Ca 2ϩ overload.
Mice with cardiac-specific ablation (exon 11 was deleted from the NCX gene) of NCX (NCX-KO) were developed using Cre/loxP technology. 17 In these mice, Ϸ80% to 90% of the myocytes expressed no NCX. These mice survive to adulthood, and myocytes have normal Ca 2ϩ transients. 17 Baseline contractility in NCX-KO hearts was modestly (Ϸ20%) decreased without any change in high-energy phosphate content, but ␤-adrenergic stimulation increased contractility to the same extent in NCX-KO hearts as in wild-type (WT) hearts. Using these mice, we examined the role of NCX in ischemia-reperfusion injury. Consistent with reverse-mode NCX activity during ischemia, we found that the rate of decline in ATP was reduced during ischemia, ischemic contracture was delayed, and maximum contracture was reduced. The NCX-KO hearts were significantly protected against ischemia-reperfusion injury using a number of indices. NCX-KO hearts had less necrosis, better recovery of contractile function, improved phosphocreatine (PCr) recovery, and reduced Na ϩ overload during reperfusion.
Materials and Methods

Isolated Perfused Mouse Hearts
Cardiac-specific NCX knockout (NCX-KO) mice created with the Cre/loxP system of gene ablation (exon 11), described previously, 17 and their wild-type littermates were used in this study. Mice were 8 to 9 weeks of age at the time of experimentation. All animals were treated in accordance with the National Institutes of Health Publication No. 8523: Guide for the Care and Use of Laboratory Animals. Hearts were isolated and perfused in the Langendorff mode as described previously. 12 Hearts were perfused with modified Krebs-Henseleit buffer containing (in mmol/L) 120 NaCl, 25 NaHCO 3 , 5.9 KCl, 1.2 MgSO 4 , 1.75 CaCl 2 , and 10 glucose, gassed with 95% O 2 /5% CO 2 at 37°C (pH 7.4). After a 20-minute stabilization period, hearts were subjected to 20 minutes of zero-flow global ischemia followed by 120 minutes of reperfusion. Left-ventricular developed pressure (LVDPϭLV peak minus end-diastolic pressure [EDP]), heart rate (HR), maximum rate of contraction (ϩdP/dt max ), and maximum rate of relaxation (ϪdP/dt min ) were monitored via a fluid-filled latex balloon in the left ventricle connected to a pressure transducer. After ischemia, the balloon was deflated during the initial 10 minutes of reperfusion to minimize the "no-reflow" phenomenon. After 10 minutes of reperfusion, the balloon was reinflated to an EDP of 20 cmH 2 O. Functional recovery was determined by the recovery of the rate pressure product (RPP) (RPPϭLVDPϫHR) during reperfusion expressed as a percentage of the preischemic value. At the end of reperfusion, the hearts were incubated with a 1% solution of 2,3,5-triphenyltetrazolium chloride dissolved in Krebs-Henseleit buffer at 37°C for 30 minutes. The hearts were fixed in formalin and then were cut into thin cross-sectional slices. The area of necrosis was quantitated by measuring the stained area (red, live tissue) versus the unstained area (white, necrotic).
Some hearts were treated with the ␤-adrenergic agonist, isoproterenol (5 nmol/L) for 5 minutes before ischemia/reperfusion. Isoproterenol was not included in reperfusion buffer. This dose was selected to achieve the same contractility and workload between WT and NCX-KO hearts before ischemia.
Isolation of Ventricular Myocytes From Adult Mouse Hearts
Ventricular myocytes were isolated by enzymatic digestion as described previously. 18 Following isolation, we stored the dissociated cells for up to 6 hours at room temperature in modified Tyrode solution, containing (in mmol/L): 136 NaCl, 5.4 KCl, 10 HEPES, 1.0 MgCl 2 , 0.33 NaH 2 PO 4 , 1.0 CaCl 2 , 10 glucose, pH 7.4 with NaOH.
Electrophysiology and [Ca 2؉ ] i Measurement
Myocytes were placed in an experimental chamber (0.5 mL) mounted on the stage of a Nikon Diaphot inverted microscope. A heated bath solution (26°C) continuously perfused the chamber. The patch electrode solution contained (in mmol/L): 110 CsCl, 30 TEA-Cl, 10 NaCl, 10 HEPES, 5 MgATP, 0.1 cAMP, 0.1 K 5 fura-2, pH 7.2 with CsOH. We controlled membrane potential using an Axopatch 200 patch clamp amplifier (Axon Instruments, Union City, Calif) and a Digidata 1320 (Axon Instruments) data acquisition system controlled by pCLAMP 9 software (Axon Instruments).
To determine [Ca 2ϩ ] i , we used a custom-designed photometric epifluorescence detection system, described in detail previously. 19 Cells were loaded with the [Ca 2ϩ ] i indicator fura-2 via the pipette solution. [Ca 2ϩ ] i was calculated from the ratio (R) of the fluorescence intensities at the two excitation wavelengths (ratios at 600 Hz) using the method of Grynkiewicz et al 20 according to the equation:
R max , R min , and ␤ were determined by measuring the fluorescence intensity of drops of internal solution containing fura-2 and either high or low Ca 2ϩ ; K d-fura ϭ224 nmol/L.
As previously reported, 10% to 20% of myocytes from NCX-KO hearts have a WT phenotype 17 ; they show an NCX-specific inward current (I NCX ) during rapid exposure (1 s) of caffeine. We excluded the myocytes with a detectable I NCX from the NCX-KO group.
Relative changes in the concentration of ATP, PCr, and intracellular pH (pH i ) were measured during ischemia/reperfusion by acquiring consecutive 5-minute 31 P-NMR spectra using a Varian 500 MHz spectrometer with an 11.7 Tesla superconducting magnet at the 31 P resonance frequency of 202.47 MHz. The pH i was calculated from the chemical shift between inorganic phosphate (P i ) and PCr from 31 P-NMR spectra as described previously. 12 Intracellular Na ϩ concentration ([Na ϩ ] i ) was measured by consecutive 2.5 minutes 23 Na-NMR spectra at the 23 Na resonance frequency of 132.4 MHz. For Na ϩ measurement, 5 mmol/L of the paramagnetic shift reagent TmDOTP 5Ϫ (thulium[III]1,4,7,10-tetra-azacyclo-dodecane-1,4,7,10tetra[methylene-phosphonic acid], sodium salt) was introduced to separate the extracellular Na ϩ peak from the intracellular Na ϩ signal. Additional CaCl 2 was added to the perfusate to compensate for binding of Ca 2ϩ to the TmDOTP 5Ϫ . Relative changes (expressed as a percent of the initial value) were reported. 21
Statistical Analysis
Results are expressed as meanϮSEM. Significance (PϽ0.05) was determined by unpaired t test (for discrete variables) and repeatedmeasures ANOVA.
Results
Animal Phenotype and Basal Contractile Performance
The Table shows basal contractile function in the NCX-KO hearts and their WT littermates. The heart weight was not significantly different between WT (0.13Ϯ0.01 g) and NCX-KO (0.14Ϯ0.01 g, PϾ0.05). As shown in the Table, left-ventricular developed pressure (LVDP), ϩdP/dt max , and ϪdP/dt min were significantly lower in NCX-KO hearts than WT. The HR was not significantly different between WT and NCX-KO hearts (PϾ0.05). These findings are consistent with the recently published echocardiographic data using an in vivo model. 17
Effects of NCX Ablation During Ischemia/Reperfusion
WT and NCX-KO mice were subjected to 20-minute zeroflow global ischemia at 37°C (nϭ10/group). As shown in Figure 1A , the time to ischemic contracture in NCX-KO hearts was significantly delayed (17.0Ϯ1.23 minutes) compared with WT hearts (10.2Ϯ1.0 minutes, PϽ0.001). Also, the maximum contracture or end-diastolic pressure during ischemia was significantly lower in NCX-KO (36Ϯ5 cmH 2 O) than in WT hearts (76Ϯ5 cmH 2 O, PϽ0.0001), consistent with reduced Ca 2ϩ entry during ischemia. On reperfusion, NCX-KO hearts showed less postischemic contractile dysfunction than WT hearts. The postischemic recovery of LVDP (expressed as a percentage of initial preischemic LVDP) was significantly better in NCX-KO (46Ϯ4%, PϽ0.0001) than in WT hearts (12Ϯ2%). Postischemic recovery of rate pressure product (RPPϭLVDPϫHR) was also significantly better in NCX-KO than in WT hearts (PϽ0.0001), as shown in Figure 1B and the Table. In addition, infarct size was significantly smaller in NCX-KO hearts (7.0Ϯ2.5% of total ventricle) than in WT hearts (49.5Ϯ8.7%, PϽ0.01; Figure 1C ). These results are consis-tent with the hypothesis that reverse-mode NCX activity contributes to ischemia/reperfusion injury.
Reverse-Mode NCX Is Absent in NCX-KO Myocytes
To confirm the absence of reverse-mode NCX in NCX-KO myocytes, we performed the experiment shown in Figure 2 . NCX reverse mode generates the influx of 1 Ca 2ϩ ion into the myocyte in exchange for 3 Na ϩ ions being extruded. Because of the electrogenic nature of this process, NCX reverse mode is favored by depolarization of the myocyte. It also depends on the Na ϩ gradient and thus the extracellular Na ϩ concentration. To provoke reverse exchange, we depolarized patch clamped myocytes from a holding potential of Ϫ40 mV to ϩ80 mV for 1 s while simultaneously removing Na ϩ from the extracellular solution using a rapid solution exchanger. In 5 WT cells, this led to an increase in [Ca 2ϩ ] i to an average peak of 486Ϯ79 nmol/L. In contrast, none of the 5 NCX-KO myocytes exhibited an increase in [Ca 2ϩ ] i using this protocol. Cells were held at Ϫ40 mV and were depolarized to ϩ80 mV for 1 s. Simultaneously, myocytes were rapidly exposed to Na ϩ -free external solution. The tracings are representative of 5 WT and 5 KO myocytes.
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Effects of NCX Ablation on Energy Metabolism and [Na ؉ ] i Regulation
To explore further the mechanism of the protection observed in NCX knockout hearts, we measured changes in [PCr], [ATP], pH i , and [Na ϩ ] i before and during ischemia/reperfusion. 31 P-NMR spectroscopy was used to measure highenergy phosphates and pH i . As shown in Figure 3 , at baseline, there were no differences in high-energy phosphates between WT and NCX-KO hearts. However, during ischemia, the rate of decline in ATP was slower in NCX-KO hearts than WT hearts (PϽ0.05). Furthermore, the recovery of ATP and PCr during reperfusion was significantly better in NCX-KO hearts than in WT hearts (PϽ0.05; Figure 4A and 4B). The slower fall in [ATP] during ischemia in NCX-KO hearts is consistent with the delay in ischemic contracture in NCX-KO hearts and may also be related to reduced Ca 2ϩ accumulation. 22 Basal pH i was similar between WT (7.22Ϯ0.03) and NCX-KO hearts (7.22Ϯ0.02; PϾ0.05), and pH i decreased similarly during ischemia. At the start of reperfusion, pH i recovered more rapidly in NCX-KO than WT hearts ( Figure 4C ), consistent with better preservation of high-energy phosphates. Taken together, these data indicate that NCX-KO have reduced ischemia/reperfusion injury. We also examined [Na ϩ ] i using 23 Na-NMR and the shift reagent TmDOTP 5Ϫ . 21 There were no differences in [Na ϩ ] i at baseline in WT hearts (14.4Ϯ0.4 mmol/L) compared with NCX-KO hearts (14.5Ϯ0.5 mmol/L; nϭ5/group, Pϭ0.51). As shown in Figure 5 , during 20 minutes of ischemia, [Na ϩ ] i increased to 189Ϯ9% of the preischemic value in WT hearts (open circles). This increase was slightly, but significantly higher than that observed in NCX-KO hearts (162Ϯ7%, PϽ0.05; closed circles). On reperfusion, [Na ϩ ] i recovered more completely in NCX-KO hearts than WT. After 40 minutes of reperfusion, [Na ϩ ] i was significantly lower in NCX-KO hearts (92Ϯ3% of preischemic) than in WT hearts (128Ϯ5%).
Effects of NCX Ablation During Ischemia After Isoproterenol Addition to Normalize Workload
Because the NCX-KO hearts have a 20% reduction in contractility at baseline, it is possible that the reduced workload at the start of ischemia may contribute to the reduced ischemic injury observed in the NCX-KO hearts. We therefore briefly treated hearts with 5 nmol/L isoproterenol for 5 minutes just before ischemia to normalize the workload at the start of ischemia. Treatment with isoproterenol resulted in a similar rate-pressure product in NCX-KO and WT hearts before ischemia, as shown in Figure 6A . The changes in PCr and ATP after addition of isoproterenol were also similar between WT and NCX-KO hearts ( Figure 6B ). Interestingly, even with workload normalized between genotypes, NCX-KO hearts exhibited reduced ischemia/reperfusion dysfunction during ischemia. As shown in Figure 6C , rate of decline in ATP was slower in NCX-KO hearts than WT hearts (PϽ0.05). Furthermore, the time to ischemic contracture was reduced in isoproterenol-treated NCX-KO hearts compared with WT hearts (WT: 10.3Ϯ0.8 minutes; NCX-KO: 15.9Ϯ2.4 minutes), as was the maximum ischemic contracture (WT: 71Ϯ5 cmH 2 O; NCX-KO: 36Ϯ12 cmH 2 O; PϽ0.05). NCX-KO hearts also showed better recovery of contractile function after reperfusion ( Figure 6D; PϽ0.05 ).
Discussion
NCX1 is ablated in 80% to 90% of the cardiomyocytes in the NCX-KO hearts. 17 These mice live to adulthood and exhibit only a 20% to 30% decrease in cardiac function as measured by echocardiography. 17 Consistent with the previous echocardiography measurements, we found a slight but significant decrease in LVDP and ϮdP/dt in NCX-KO hearts. We observed no change in baseline energy metabolism in the NCX-KO hearts compared with WT hearts, suggesting that the decrease in contractility is not caused by a decrease in high-energy phosphates. The decrease in baseline contractility in NCX-KO mice is likely attributable to altered Ca 2ϩ handling, but it is very surprising that contractility is not altered to an even greater extent in the NCX-KO hearts. Furthermore, the contractile and metabolic responses to isoproterenol are similar between WT and NCX-KO hearts, indicating that NCX-KO hearts can achieve the same contractility as WT hearts. By voltage clamp measurement, the L-type Ca 2ϩ -channel current was previously reported to be reduced by 50% in the NCX-KO hearts, although there were no adaptive changes in protein levels of sarcoplasmic/endoplasmic reticulum Ca 2ϩ ATPase, the plasma membrane Ca 2ϩ ATPase, or the dihydropyridine receptor (L-type Ca 2ϩ channel) and no difference in sarcoplasmic reticular Ca 2ϩ content. 17 We show here that the lack of NCX also does not alter basal intracellular Na ϩ , suggesting that [Na ϩ ] i is set by the Na ϩ /K ϩ -ATPase and not NCX. The NCX-KO hearts also exhibit no difference in basal pH i .
Role of NCX in Ischemia/Reperfusion Injury
Attenuating the rise in Na ϩ during ischemia has been shown to decrease the rise in Ca 2ϩ during ischemia. This has been taken as support for a role of NCX in the rise in [Ca 2ϩ ] i . 4, 6 However, NCX operates near equilibrium, and it is unclear whether the beneficial Na ϩ -dependent effects on Ca 2ϩ during ischemia are attributable to improved Ca 2ϩ efflux (via forward mode NCX) or reduced Ca 2ϩ influx (via reverse-mode NCX). As inhibition of NCX is a current target for drug development to reduce ischemic injury, it is important to determine whether NCX operates in the forward mode or reverse mode during ischemia. Inhibition of exchange would have opposite effects in the 2 cases. The availability of mice with cardiac-specific ablation of NCX in 80% to 90% of the myocytes provides an ideal opportunity to directly evaluate the role of NCX in ischemia/reperfusion injury. Figure 2 clearly demonstrates that reverse-mode Ca 2ϩ influx into the myocyte is absent in NCX-KO mice. Our data further show that ablation of NCX results in a significant improvement in postischemic function and significantly less myocyte death. NCX-KO hearts also exhibit less of a decline in ATP during ischemia and significantly better recovery of ATP and PCr on reperfusion. This improvement in postischemic function and reduced rate of decline in ATP during ischemia was still observed in isoproterenol-treated NCX-KO hearts, indicating that the protection observed in NCX-KO hearts is maintained when workload at the start of ischemia is normalized. Taken together, these data clearly show that lack of NCX is beneficial during ischemia. Ablation of NCX would not be beneficial if NCX primarily extruded Ca 2ϩ from the cell (ie, net Ca 2ϩ efflux) during ischemia. These data support the hypothesis that inhibition of Ca 2ϩ entry via reverse-mode NCX is protective.
NCX During Ischemia Versus Reperfusion
Intracellular Na ϩ rises during ischemia, as shown in this article and in several previously published studies. 6, 21, 23, 24 Because of the marked decrease in pH i during ischemia, it has generally been assumed that NCX becomes inhibited. 25 Although NCX activity is reduced at low pH, it is not totally inhibited, particularly under conditions of elevated [Na ϩ ] i . 26, 27 The increase in [Ca 2ϩ ] i during ischemia has been shown to be modulated by intracellular Na ϩ , suggesting that NCX operates during ischemia. 4 Data in this article also indicate that NCX is active during ischemia. If NCX were totally inhibited during ischemia, then one would not expect differences during ischemia between NCX-KO and WT hearts. During ischemia we observed a slower decline in ATP, a slower rate of ischemic contracture, a reduced maximum contracture, and less of a rise in intracellular Na ϩ in NCX-KO hearts. Taken together, these data suggest increased Ca 2ϩ entry via NCX during ischemia in WT hearts. The lack of Ca 2ϩ entry via the reverse-mode NCX would decrease the detrimental effects of Ca 2ϩ overload and better preserve ATP, which would prolong the activity of the Na ϩ /K ϩ -ATPase, 28, 29 leading to less Na ϩ accumulation during ischemia in NCX-KO hearts. On reperfusion, the better-preserved ATP in the NCX-KO hearts facilitates Na ϩ extrusion by Na ϩ /K ϩ -ATPase. 28 -30 
Role of Na ؉ Versus Ca 2؉ in Ischemia/Reperfusion Injury
Attenuating the rise in [Ca 2ϩ ] i during ischemia using NHE inhibitors has been shown to reduce ischemia/reperfusion injury, suggesting a causal role for elevated Ca 2ϩ in the genesis of irreversible myocyte injury. 31 However, inhibition of NHE reduces the rise in Na ϩ as well as the rise in Ca 2ϩ during ischemia. The rise in Na ϩ has been suggested to have detrimental effects that occur independent of the effects on Ca 2ϩ . 15, 16 With inhibition of NHE, we previously reported a complete block in the rise in Na ϩ during ischemia, 4 whereas in the current study we find that loss of NCX causes only 10% reduction in the rise in Na ϩ during ischemia. Despite these differences in Na ϩ during ischemia, the protection was similar (an Ϸ3-fold improvement in recovery of LVDP) with NHE inhibitors compared with NCX-KO hearts. Taken together, these data suggest that a rise in Na ϩ per se during ischemia is not a major determinant of ischemia/reperfusion injury. 6 In summary, hearts from mice lacking NCX have significantly less ischemia/reperfusion injury than WT hearts when subjected to a global model of ischemia. NCX-KO hearts have less necrosis, improved postischemic LVDP, higher levels of high-energy phosphates, and improved recovery of ion homeostasis. These data suggest that inhibition of NCX is a promising target for cardiac protection.
